1. Home
  2. CING vs SFHG Comparison

CING vs SFHG Comparison

Compare CING & SFHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CING
  • SFHG
  • Stock Information
  • Founded
  • CING 2012
  • SFHG 1993
  • Country
  • CING United States
  • SFHG Hong Kong
  • Employees
  • CING N/A
  • SFHG N/A
  • Industry
  • CING Biotechnology: Pharmaceutical Preparations
  • SFHG Publishing
  • Sector
  • CING Health Care
  • SFHG Consumer Discretionary
  • Exchange
  • CING Nasdaq
  • SFHG Nasdaq
  • Market Cap
  • CING 17.3M
  • SFHG 18.9M
  • IPO Year
  • CING 2021
  • SFHG 2024
  • Fundamental
  • Price
  • CING $5.50
  • SFHG $0.81
  • Analyst Decision
  • CING Strong Buy
  • SFHG
  • Analyst Count
  • CING 4
  • SFHG 0
  • Target Price
  • CING $30.67
  • SFHG N/A
  • AVG Volume (30 Days)
  • CING 104.9K
  • SFHG 63.6K
  • Earning Date
  • CING 08-12-2025
  • SFHG 08-05-2025
  • Dividend Yield
  • CING N/A
  • SFHG N/A
  • EPS Growth
  • CING N/A
  • SFHG N/A
  • EPS
  • CING N/A
  • SFHG N/A
  • Revenue
  • CING N/A
  • SFHG $19,760,935.00
  • Revenue This Year
  • CING N/A
  • SFHG N/A
  • Revenue Next Year
  • CING N/A
  • SFHG N/A
  • P/E Ratio
  • CING N/A
  • SFHG N/A
  • Revenue Growth
  • CING N/A
  • SFHG 30.89
  • 52 Week Low
  • CING $1.80
  • SFHG $0.55
  • 52 Week High
  • CING $20.83
  • SFHG $24.00
  • Technical
  • Relative Strength Index (RSI)
  • CING 66.64
  • SFHG N/A
  • Support Level
  • CING $4.25
  • SFHG N/A
  • Resistance Level
  • CING $6.01
  • SFHG N/A
  • Average True Range (ATR)
  • CING 0.34
  • SFHG 0.00
  • MACD
  • CING 0.09
  • SFHG 0.00
  • Stochastic Oscillator
  • CING 71.02
  • SFHG 0.00

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

About SFHG Samfine Creation Holdings Group Limited Ordinary Share

Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.

Share on Social Networks: